Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + Chemotherapy in 2nd-line Metastatic Colorectal Cancer
NCT01181609Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2005
- Primary completion
- May 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Roche. Started Jun 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01181609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181609.